Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

haemophilus

haemophilus is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 14
Pipeline programs 2
News articles 0
Drug details — haemophilus
Class
—
Route
—
Patents
14
Programs
2
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

haemophilus is an FDA-listed pharmaceutical active ingredient.

Key facts

INN haemophilus

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free) Phase 2 · BRIGHT MINDS BIOSCIENCES · Meningitis
  2. VAN00013 Phase 2 · Sanofi-Aventis U.S · Meningococcal immunization

Related patents

Browse patents

  1. US 12220453

    Compositions and treatments for Haemophilus influenzae

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11305002

    Compositions and treatments for Haemophilus influenzae

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9034642

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8911743

    Haemophilus parasuis polypeptides and methods of use

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8628917

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8283114

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7998490

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7816086

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7638282

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7514529

    Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7241867

    Polypeptide encoded by a nucleotide sequence of a nontypeable strain of Haemophilus influenzae genome

    Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 6607725

    Conjugate vaccine for nontypeable Haemophilus influenzae

    Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6420134

    Vaccines for nontypable haemophilus influenzae

    Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6207157

    Conjugate vaccine for nontypeable Haemophilus influenzae

    Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is haemophilus?

haemophilus is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.